Category Archives: Licensing and Deal Making

Fool Me Once, Shame on Me: Lessons from Royalty Negotiations, Part 1

Negotiating royalties is challenging under the best of circumstances. In this three-part series, I outline several real-world examples of successes, near-failures, and collapsed deals. Not surprisingly, in the failed and nearly failed deals, emotions and personal objectives rather than business … Continue reading

Posted in Licensing and Deal Making, Stories From the Field | Comments Off on Fool Me Once, Shame on Me: Lessons from Royalty Negotiations, Part 1

NASA’s Research Helps in the Fight Against Cancer

A NASA technology originally developed for the space program has evolved into a state-of-the-art medical device that increases the effectiveness of chemotherapy treatments and provides natural, drug-free pain relief for thousands of Americans. Continue reading

Posted in Licensing and Deal Making | Comments Off on NASA’s Research Helps in the Fight Against Cancer

FDA Allows NASA-Based Device to Be Used in Medical Imaging

I’ve said it before, and I’ll say it again: You have to be patient when it comes to technology licensing—especially if you’re talking about commercialization of an innovation for medical use. Yesterday, in conjunction with Breast Cancer Awareness Month, NASA’s … Continue reading

Posted in Licensing and Deal Making, Technology Commercialization Processes | Comments Off on FDA Allows NASA-Based Device to Be Used in Medical Imaging

NASA Technology Enables Vision Screening for Millions of U.S. Children

As any parent knows, it can be a challenge for young children to sit still during an eye exam, let alone respond to a series of questions about what they are seeing. In the case of infants and pre-verbal children, … Continue reading

Posted in Licensing and Deal Making | Comments Off on NASA Technology Enables Vision Screening for Millions of U.S. Children

Metrics to Measure Your Technology Licensing Success: The M in PRISM

Editor’s note: This is the last in a six-post series on how Fuentek views technology licensing through a new PRISM. Metrics are one of the most challenging aspects of licensing that any technology transfer office (TTO) faces when pursuing commercialization … Continue reading

Posted in Licensing and Deal Making, Metrics, Technology Commercialization Processes | Tagged | Comments Off on Metrics to Measure Your Technology Licensing Success: The M in PRISM

Using Consistency to Streamline Your Technology Licensing Process: The S in PRISM

Editor’s note: This is the fifth in a six-post series on how Fuentek views technology licensing through a new PRISM. Many people cite Winston Churchill as saying that “Consistency is the hobgoblin of little minds.” But there is a key … Continue reading

Posted in Licensing and Deal Making, Technology Commercialization Processes | Comments Off on Using Consistency to Streamline Your Technology Licensing Process: The S in PRISM

The Ins and Outs of Information Management in Technology Licensing: The I in PRISM

Updated Oct. 12, 2010 Editor’s note: This is the fourth in a six-post series on how Fuentek views technology licensing through a new PRISM. Success in pursuing proactive intellectual property (IP) management and technology commercialization depends upon having a solid … Continue reading

Posted in Competitive Intelligence, Licensing and Deal Making, Technology Commercialization Processes | Comments Off on The Ins and Outs of Information Management in Technology Licensing: The I in PRISM

Viewing Technology Licensing through a New PRISM

Blog Series Viewing Technology Licensing through a New PRISM This collection of blog posts outlines Fuentek’s Prioritize, ROI, Information Management, Streamline, Measure focus. Download PDF.

Posted in Licensing and Deal Making, Technology Commercialization Processes | Tagged , | Comments Off on Viewing Technology Licensing through a New PRISM

Calculating the R and I in ROI: The R in PRISM of Technology Licensing

Editor’s note: This is the third in a six-post series on how Fuentek views technology licensing through a new PRISM. How do you decide if the return is worth the investment when you’re prioritizing your technology licensing opportunities? There are … Continue reading

Posted in Licensing and Deal Making, Technology Commercialization Processes | Comments Off on Calculating the R and I in ROI: The R in PRISM of Technology Licensing

Always Prioritize Your Technology Licensing Opportunities: The P in PRISM

Editor’s note: This is the second in a six-post series on how Fuentek views technology licensing through a new PRISM. Whether your intellectual property (IP) portfolio is small or enormous, prioritizing your commercialization opportunities let’s you put your money and … Continue reading

Posted in Licensing and Deal Making, Technology Commercialization Processes | Comments Off on Always Prioritize Your Technology Licensing Opportunities: The P in PRISM